// App-Quantinova.ai

TCT-58 : Long-term clinical outcomes of patients treated with everolimus-eluting bioresorbable scaffolds during daily practice 2-year results from the ISAR-ABSORB Registry

Researchers

Presenter

  • Jens Wiebe

Principal Investigators

  • Petra Hoppmann

  • Sebastian Kufner

  • Salvatore Cassese

  • Yukinori Harada

  • Roisin Colleran

  • Erion Xhepa

  • Janika Repp

  • Simon Schneider

  • Tareq Ibrahim

  • Heribert Schunkert

Medical Centers

  • Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Munich, Germany

  • Deutsches Herzzentrum Munchen, Munich, Germany

  • II. Medizinische Klinik und Poliklinik Klinikum rechts der Isar der Technischen Universitat Munchen, Munchen, Germany.

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved